In a retrospective analysis of a cohort from Spain of HIV-infected women with CD4+ cell counts >350 cells/mm3 and with no previous SIL, there was no significant difference in SIL incidence between groups receiving versus not receiving HAART[28]. The gene discussed is CD4; the disease is squamous cell intraepithelial neoplasia.